The Tumor Ablation Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the tumor ablation market has significantly increased recently. The market's size is predicted to rise from $1.45 billion in 2024 and reach $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 12.1%. The historical growth trend in this market has seen a remarkable rate of increase.
By 2029, the tumor ablation market is anticipated to reach a size of $2.54 billion, growing at a Compound Annual Growth Rate (CAGR) of 11.8%.
Download Your Free Sample of the 2025 Tumor Ablation Market Report and Uncover Key Trends Now!The drivers in the tumor ablation market are:
• The evolution and advancement of precise and efficient ablation techniques.
• Rising healthcare expenditure across emerging economies.
• An aging population contributing to increased occurrence of cancer.
• Worldwide increase in cancer occurrence and growing awareness.
The tumor ablation market covered in this report is segmented –
1) By Type: Thermal Ablation, Chemical Ablation
2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer
4) By End Users: Hospitals, Oncology Centers, Other End Users
The trends in the tumor ablation market are:
• Technological advancements continue to shape the future of the Tumor Ablation market.
• The development of advanced ablation technologies is a noticeable emerging trend.
• The integration of artificial intelligence into this field is a significant factor.
• There is a growing trend towards outpatient settings and patient-centric approaches.
The major players in the tumor ablation market are:
• Abbott Laboratories
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation
• Boston Scientific Corporation
• Olympus Corporation
• Terumo Cor
North America was the largest region in the tumor ablation market in 2024